|
2014 Journal Article Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patientsDe Waele, Jan J., Lipman, J., Akova, M., Bassetti, M., Dimopoulos, G., Kaukonen, M., Koulenti, D., Martin, C., Montravers, P., Rello, J., Rhodes, A., Udy, A. A., Starr, T., Wallis, S. C. and Roberts, J. A. (2014). Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients. Intensive Care Medicine, 40 (9), 1340-1351. doi: 10.1007/s00134-014-3403-8 |
|
2014 Journal Article Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI StudyRoberts, J. A., Stove, V., De Waele, J. J., Sipinkoski, B., McWhinney, B., Ungerer, J. P. J., Akova, M., Bassetti, M., Dimopoulos, G., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., Rello, J., Rhodes, A., Starr, T., Wallis, S. C. and Lipman, J. (2014). Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study. International Journal of Antimicrobial Agents, 43 (5), 423-430. doi: 10.1016/j.ijantimicag.2014.01.023 |
|
2013 Journal Article Clinical implications of antibiotic pharmacokinetic principles in the critically illUdy, Andrew A., Roberts, Jason A. and Lipman, Jeffrey (2013). Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Medicine, 39 (12), 2070-2082. doi: 10.1007/s00134-013-3088-4 |
|
2013 Journal Article B-type natriuretic peptide: not just a heart throbParatz, Jennifer and Lipman, Jeffrey (2013). B-type natriuretic peptide: not just a heart throb. A & A Case Reports, 1 (4), 59-61. doi: 10.1097/ACC.0b013e31829737ab |
|
2013 Journal Article A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrationsUdy, Andrew A., Morton, Fraser J. A., Nguyen-Pham, Sallyanne, Jarrett, Paul, Lassig-Smith, Melissa, Stuart, Janine, Dunlop, Rachel, Starr, Therese, Boots, Robert J. and Lipman, Jeffrey (2013). A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations. BMC Nephrology, 14 (1) 250, 250. doi: 10.1186/1471-2369-14-250 |
|
2013 Journal Article Ampicillin/sulbactam: Its potential use in treating infections in critically ill patientsAdnan, Syamhanin, Paterson, David L., Lipman, Jeffrey and Roberts, Jason A. (2013). Ampicillin/sulbactam: Its potential use in treating infections in critically ill patients. International Journal of Antimicrobial Agents, 42 (5), 384-389. doi: 10.1016/j.ijantimicag.2013.07.012 |
|
2013 Journal Article Molecular analysis of the Acinetobacter baumannii biofilm-associated proteinGoh, H. M. Sharon, Beatson, Scott A., Totsika, Makrina, Moriel, Danilo G., Phan, Minh-Duy, Szubert, Jan, Runnegar, Naomi, Sidjabat, Hanna E., Paterson, David L., Nimmo, Graeme R., Lipman, Jeffrey and Schembri, Mark A. (2013). Molecular analysis of the Acinetobacter baumannii biofilm-associated protein. Applied and Environmental Microbiology, 79 (21), 6535-6543. doi: 10.1128/AEM.01402-13 |
|
2013 Journal Article Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumanniiMoriel, Danilo G., Beatson, Scott A., Wurpel, Daniël J., Lipman, Jeffrey, Nimmo, Graeme R., Paterson, David L. and Schembri, Mark A. (2013). Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii. PLoS ONE, 8 (10) e77631, e77631.1-e77631.9. doi: 10.1371/journal.pone.0077631 |
|
2013 Journal Article What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic reviewParker, Suzanne, Lipman, Jeffrey, Koulenti, Despoina, Dimopoulos, George and Roberts, Jason A. (2013). What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review. International Journal of Antimicrobial Agents, 42 (4), 289-293. doi: 10.1016/j.ijantimicag.2013.05.018 |
|
2013 Journal Article A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II studyDulhunty, Joel M., Roberts, Jason A., Davis, Joshua S., Webb, Steven A. R., Bellomo, Rinaldo, Gomersall, Charles, Shirwadkar, Charudatt, Eastwood, Glenn M., Myburgh, John, Paterson, David L., Starr, Therese, Udy, Andrew A., Paul, Sanjoy K. and Lipman, Jeffrey (2013). A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study. Critical Care and Resuscitation, 15 (3), 179-185. |
|
2013 Journal Article Phenytoin loading doses in adult critical care patients: does current practice achieve adequate drug levels?Putt, M. T., Udy, A. A., Jarrett, P., Martin, J., Hennig, S., Salmon, N., Lipman, J. and Roberts, J. A. (2013). Phenytoin loading doses in adult critical care patients: does current practice achieve adequate drug levels?. Anaesthesia and Intensive Care, 41 (5), 602-609. doi: 10.1177/0310057x1304100505 |
|
2013 Journal Article Antibiotic prescription for respiratory tract infections in ventilated patients: where are we heading?Rello, Jordi and Lipman, Jeffrey (2013). Antibiotic prescription for respiratory tract infections in ventilated patients: where are we heading?. Intensive Care Medicine, 39 (9), 1644-1646. doi: 10.1007/s00134-013-2983-z |
|
2013 Journal Article Reply to Soman et alDulhunty, Joel M., Roberts, Jason A., Davis, Joshua S., Webb, Steven A. R., Bellomo, Rinaldo, Gomersall, Charles, Shirwadkar, Charudatt, Eastwood, Glenn M., Myburgh, John, Paterson, David L. and Lipman, Jeffrey (2013). Reply to Soman et al. Clinical Infectious Diseases, 57 (2), 323-324. doi: 10.1093/cid/cit201 |
|
2013 Journal Article Clinical measures for increased creatinine clearances and suboptimal antibiotic dosingPletz, Mathias W. and Lipman, Jeffrey (2013). Clinical measures for increased creatinine clearances and suboptimal antibiotic dosing. Intensive Care Medicine, 39 (7), 1322-1324. doi: 10.1007/s00134-013-2918-8 |
|
2013 Journal Article Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drainsAdnan, Syamhanin, Li, Janice Xuanhui, Wallis, Steven C., Rudd, Michael, Jarrett, Paul, Paterson, David L., Lipman, Jeffrey, Udy, Andrew A. and Roberts, Jason A. (2013). Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains. International Journal of Antimicrobial Agents, 42 (1), 90-93. doi: 10.1016/j.ijantimicag.2013.02.023 |
|
2013 Journal Article Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?Udy, Andrew A., Covajes, Cecilia, Taccone, Fabio Silvio, Jacobs, Frederique, Vincent, Jean-Louis, Lipman, Jeffrey and Roberts, Jason A. (2013). Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?. International Journal of Antimicrobial Agents, 41 (6), 564-568. doi: 10.1016/j.ijantimicag.2013.01.018 |
|
2013 Journal Article Meropenem and piperacillin/tazobactam prescribing in critically ill patients: Does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Carlier, Mieke, Carrette, Sofie, Roberts, Jason A., Stove, Veronique, Verstraete, Alain, Hoste, Eric, Depuydt, Pieter, Decruyenaere, Johan, Lipman, Jeffrey, Wallis, Steven C. and De Waele, Jan J. (2013). Meropenem and piperacillin/tazobactam prescribing in critically ill patients: Does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?. Critical Care, 17 (3) R84, R84.1-R84.9. doi: 10.1186/cc12705 |
|
2013 Journal Article How should we dose antibiotics for pneumonia in the ICU?Udy, Andrew A., Roberts, Jason A. and Lipman, Jeffrey (2013). How should we dose antibiotics for pneumonia in the ICU?. Current Opinions in Infectious Diseases, 26 (2), 189-195. doi: 10.1097/QCO.0b013e32835d19e0 |
|
2013 Journal Article Towards improved surveillance: the impact of ventilator-associated complications (VAC) on length of stay and antibiotic use in patients in intensive care unitsHayashi, Yoshiro, Morisawa, Kenichiro, Klompas, Michael, Jones, Mark, Bandeshe, Hiran, Boots, Robert, Lipman, Jeffrey and Paterson, David L. (2013). Towards improved surveillance: the impact of ventilator-associated complications (VAC) on length of stay and antibiotic use in patients in intensive care units. Clinical Infectious Diseases, 56 (5), 471-477. doi: 10.1093/cid/cis926 |
|
2013 Journal Article Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance and decreased bacterial susceptibilityRoberts, Jason and Lipman, Jeffrey (2013). Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance and decreased bacterial susceptibility. Critical Care Medicine, 41 (2), 489-495. doi: 10.1097/CCM.0b013e31826ab4c4 |
